Filing Flows › Ocular Therapeutix (OCUL) › Guidance history
Ocular Therapeutix (OCUL) guidance history: what it guided and what it reported
Ocular Therapeutix gave guidance in 1 earnings release on file since Nov 9, 2026.
Capital expenditures
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $20.0M (Nov 9, 2026) | — | to be reported | — |
The latest quarter
Ocular Therapeutix, Q3 2026: revenue $12.9M (-12% year over year), operating margin -760.1%, net loss $94.8M, operating cash flow −$65.6M. The chart follows the revenue to costs, profit and cash.
Questions
Does Ocular Therapeutix beat its guidance?
Ocular Therapeutix gave guidance in 1 earnings release on file since Nov 9, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.